Published July 30, 2024
| Version v1
Patent
Open
Compositions and methods for activating NRF2-dependent gene expression
Creators
- 1. University of Chicago
Contributors
Patent applicant:
Description
Embodiments are directed to a series of novel small molecule activators of NRF2 dependent gene expression that are evaluated in an effort to develop therapeutic methods against diseases with deregulated KEAP1-NRF2 signaling.
Files
US_12048686_B2.pdf
Files
(3.2 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:62a74a8b1c8089352baf4152f84412a7
|
3.2 MB | Preview Download |
Additional details
Identifiers
- Patent application number
- 201917309017
- Patent number
- US 12048686 B2
- Other
- oai:uchicago.tind.io:14139
Dates
- Patent filed
-
2019-10-14